Key facts
- This page summarizes Michael E. Prevoznik's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Dec 2024, 16:43.
Michael E. Prevoznik - 29 Nov 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP & General Counsel
- Issuer ticker
- DGX
- Reported as of
- 29 Nov 2024
- Net transaction value
- -$5,731,302
- SEC form
- 4
- Accepted by SEC
- 02 Dec 2024, 16:43:18 UTC
- Prior SEC filing
- 03 Sep 2024
- Next SEC filing
- 14 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Prevoznik filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 02 Dec 2024.
Change
- Previous filing in this sequence was filed on 03 Sep 2024.
- Current net transaction value: -$5,731,302.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Options Exercise
- Transaction value
- $3,044,698
- Shares
- +35,146
- Change %
- +91%
- Price
- $86.63
- Shares after
- 73,624
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- $488,237
- Shares
- -3,009
- Change %
- -4.1%
- Price
- $162.26
- Shares after
- 70,615
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F1, F2
DGX
transaction
Common Stock
Sale
- Transaction value
- $5,243,065
- Shares
- -32,137
- Change %
- -46%
- Price
- $163.15
- Shares after
- 38,478
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F1, F3
DGX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,618
- Date
- 29 Nov 2024
- Ownership
- 401(k)/SDCP
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Options Exercise
- Transaction value
- $3,044,698
- Shares
- -35,146
- Change %
- -100%
- Price
- $86.63
- Shares after
- 0
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,146
- Exercise price
- $86.63
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $161.690 to $162.680. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $162.705 to $163.615. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F4
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Footnote F5
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.